Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Several home remedies and lifestyle modifications can help you or your partner stop snoring. You can stop snoring without ...

Multiple wildfires in Southern California have destroyed homes, caused at least 10 deaths and forced tens of thousands of people to evacuate. California Gov. Gavin Newsom declared a state of emergency ...

Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions ...

About Fexlamose Fexlamose is being developed as a chronic treatment for ... for mucus plugs in COPD and other muco-obstructive lung diseases has been slowed by a lack of predictive and monitoring ...

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) ...

More information: Screening Patients for Physical Inactivity Helps Identify Patients at Risk for Cardiometabolic and Chronic Diseases, Preventing Chronic Disease (2024). Lucas J. Carr et al ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

SIMEOX 200 is predominantly aimed to help patients with chronic lung diseases associated with mucus hypersecretion and mucus retention, such as Bronchiectasis, COPD (Chronic Obstructive Pulmonary ...